ALPS Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
|
|||||
|
2025
Q1 | $2.26M | Sell |
|
|||||
|
2024
Q4 | $3.83M | Buy |
|
|||||
|
2024
Q3 | $3.1M | Sell |
|
|||||
|
2024
Q2 | $2.76M | Buy |
|
|||||
|
2024
Q1 | $2.57M | Buy |
|
|||||
|
2023
Q4 | $1.64M | Buy |
|
|||||
|
2023
Q3 | $1.2M | Buy |
|
|||||
|
2023
Q2 | $716K | Buy |
|
|||||
|
2023
Q1 | $570K | Sell |
|
|||||
|
2022
Q4 | $668K | Buy |
|
|||||
|
2022
Q3 | $576K | Sell |
|
|||||
|
2022
Q2 | $592K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $1.56M | Buy |
|
|||||
|
2021
Q3 | $999K | Sell |
|
|||||
|
2021
Q2 | $933K | Sell |
|
|||||
|
2021
Q1 | $910K | Buy |
|
|||||
|
2020
Q4 | $839K | Buy |
|
|||||
|
2020
Q3 | $657K | Sell |
|
|||||
|
2020
Q2 | $785K | Buy |
|
|||||
|
2020
Q1 | $647K | Sell |
|
|||||
|
2019
Q4 | $1.23M | Buy |
|
|||||
|
2019
Q3 | $725K | Sell |
|
|||||
|
2019
Q2 | $1.26M | Buy |
|